The Prevention of Rh Disease of Newborns in Pakistan

CompletedOBSERVATIONAL
Enrollment

1,654

Participants

Timeline

Start Date

June 27, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

February 28, 2020

Conditions
Rhesus DiseaseAnti-D (Rh) Antibodies Affecting Care of Mother
Interventions
DRUG

RhIg prophylaxis

Two RhIg prophylaxis injections for Rh negative women

DEVICE

ELDONCARD

ELDONCARD point-of-care test.

DIAGNOSTIC_TEST

ELDONCARD Test

LHVs will perform ELDONCARD test.

Trial Locations (1)

74800

Taluka Headquarter Hospital Johi and District Headquarter Hospital Dadu, Goth Dado

All Listed Sponsors
collaborator

The Hospital for Sick Children

OTHER

collaborator

Grand Challenges Canada

OTHER

lead

Aga Khan University

OTHER

NCT03297671 - The Prevention of Rh Disease of Newborns in Pakistan | Biotech Hunter | Biotech Hunter